ApoA-I Mimetic 5a Peptide Exerts Potent Anti-Inflammatory Effects In Vivo and In Vitro and Ameliorates Experimental DSS Colitis

被引：0
|
作者：
Nowacki, Tobias M.
Nofer, Jerzy-Roch
Bettenwonh, Dominik
Eisenblaetter, Michel
Tepasse, Phil-Robin
Remaley, Alan T.
Luegering, Andreas
Heidemann, Jan
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S516 / S516
页数：1
相关论文
共 50 条
  • [1] The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration
    Nowacki, Tobias M.
    Remaley, Alan T.
    Bettenworth, Dominik
    Eisenblaetter, Michel
    Vowinkel, Thorsten
    Becker, Felix
    Vogl, Thomas
    Roth, Johannes
    Tietge, Uwe J.
    Luegering, Andreas
    Heidemann, Jan
    Nofer, Jerzy-Roch
    BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (18) : 2780 - 2792
  • [2] THE 5A APOA-I MIMETIC PEPTIDE DISPLAYS ANTI-INFLAMMATORY AND ANTIOXIDANT PROPERTIES MEDIATED BY ABCA1
    Tabet, F.
    Remaley, A.
    Barter, P.
    Rye, K-a
    Lambert, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [3] Mechanism for hypertriglyceridemia caused by treatment with apoA-I or the 5a apoA-I mimetic peptide
    Amar, Marcelo J.
    Pryor, Milton
    Demosky, Steve
    Stonik, John
    Remaley, Alan T.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E58 - E59
  • [4] Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring Cholesterol Esterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo
    Bucci, Mariarosaria
    Cigliano, Luisa
    Vellecco, Valentina
    D'Andrea, Luca Domenico
    Ziaco, Barbara
    Rossi, Antonietta
    Sautebin, Lidia
    Carlucci, Alessandro
    Abrescia, Paolo
    Pedone, Carlo
    Ianaro, Angela
    Cirino, Giuseppe
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 340 (03): : 716 - 722
  • [5] Anti-Inflammatory Effects of ApoA-I in Experimental Colitis Through Inhibition of Intestinal Monocyte Infiltration and Activiation
    Nowacki, Tobias M.
    Bettenworth, Dominik
    Tepasse, Phil R.
    Remaley, Alan T.
    Vowinkel, Thorsten
    Luegering, Andreas
    Nofer, Jerzy-Roch
    GASTROENTEROLOGY, 2014, 146 (05) : S112 - S112
  • [6] Mechanism for Atheroprotection in Mice by 5A, a bi-helical ApoA-I Mimetic Peptide
    Amar, Marcelo J.
    Demosky, Steve
    Stonick, John
    Voogt, Jason
    Turner, Scott
    Nigora, Mukhamedova
    Sviridov, Dmitri
    Remaley, Alan T.
    CIRCULATION, 2008, 118 (18) : S410 - S410
  • [7] ApoA-I mimetic peptide 5A boosts remyelination by promoting myelin debris clearance
    Vanherle, S.
    Dierckx, T.
    Loix, M.
    Jorissen, W.
    Gervois, P.
    Lambrichts, I.
    Dehairs, J.
    Swinnen, J.
    Mulder, M.
    Remaley, A.
    Haidar, M.
    Bogie, J.
    Hendriks, J.
    GLIA, 2021, 69 : E528 - E528
  • [8] The ApoA-I peptide mimetic 5A protects against atherosclerosis in apoE deficient mice
    Amar, Marcelo J.
    Basso, Federica
    Demosky, Steve
    Stonick, John
    Remaley, Alan T.
    CIRCULATION, 2006, 114 (18) : 23 - 23
  • [9] The ApoA-I mimetic peptide 5A enhances remyelination by promoting clearance and degradation of myelin debris
    Vanherle, Sam
    Jorissen, Winde
    Dierckx, Tess
    Loix, Melanie
    Grajchen, Elien
    Mingneau, Fleur
    Guns, Jeroen
    Gervois, Pascal
    Lambrichts, Ivo
    Dehairs, Jonas
    Swinnen, Johannes, V
    Mulder, Monique T.
    Remaley, Alan T.
    Haidar, Mansour
    Hendriks, Jerome J. A.
    Bogie, Jeroen J. F.
    CELL REPORTS, 2022, 41 (06):
  • [10] An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide
    Wool, Geoffrey D.
    Vaisar, Tomas
    Reardon, Catherine A.
    Getz, Godfrey S.
    JOURNAL OF LIPID RESEARCH, 2009, 50 (09) : 1889 - 1900
12345